Clinical Trials List
2024-04-01 - 2026-09-01
Phase III
Recruiting6
ICD-10I50.20
Unspecified systolic (congestive) heart failure
ICD-10I50.21
Acute systolic (congestive) heart failure
ICD-10I50.22
Chronic systolic (congestive) heart failure
ICD-10I50.23
Acute on chronic systolic (congestive) heart failure
ICD-10I50.30
Unspecified diastolic (congestive) heart failure
ICD-10I50.31
Acute diastolic (congestive) heart failure
ICD-10I50.32
Chronic diastolic (congestive) heart failure
ICD-10I50.33
Acute on chronic diastolic (congestive) heart failure
ICD-10I50.40
Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.41
Acute combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.42
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.43
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.9
Heart failure, unspecified
ICD-9428.0
Congestive heart failure
-
Trial Applicant
GEORGE CLINICAL ASIA PACIFIC LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 李慶威 Division of Cardiovascular Diseases
- 蔡依霖 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- Tze-Fan Chao Division of Cardiovascular Diseases
- 郭泠 Division of Cardiovascular Diseases
- Chern-En Chiang
- 吳承學
- 黃少嵩 Division of Cardiovascular Diseases
- 廖若男 Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- 張俊欽 Division of Cardiovascular Diseases
- Hao-min Cheng
- Tse-Min Lu Division of Others -
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林岳鴻 Division of Cardiovascular Diseases
- 顏志軒 Division of Cardiovascular Diseases
- 吳培甄 Division of Cardiovascular Diseases
- 黃文弘 Division of Cardiovascular Diseases
- 宋國慈 Division of Cardiovascular Diseases
- 蕭智忠 Division of Cardiovascular Diseases
- 朱柏樺 Division of Cardiovascular Diseases
- 莊梅梅 Division of Cardiovascular Diseases
- 吳書豪 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃奭毓 Division of Cardiovascular Diseases
- 簡韶甫 Division of Cardiovascular Diseases
- 陳玠宇 Division of Cardiovascular Diseases
- 李浩維 Division of Cardiovascular Diseases
- 張釗監 Division of Cardiovascular Diseases
- 蘇彥伯 Division of Cardiovascular Diseases
- 張嘉修 Division of Cardiovascular Diseases
- 郭志東 Division of Cardiovascular Diseases
- 黃晨祐 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 卓士傑 Division of Cardiovascular Diseases
- 朱志生 Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
208 participants
-
Global
5200 participants
